Rebecca M. Shulman, MD (@rebeccamshulman) 's Twitter Profile
Rebecca M. Shulman, MD

@rebeccamshulman

Radiation oncologist at Fox Chase Cancer Center Views = my own

ID: 1340101654025297920

calendar_today19-12-2020 01:08:35

63 Tweet

76 Followers

80 Following

Fox Chase Cancer Center (@foxchasecancer) 's Twitter Profile Photo

In a study published in the journal Nature, researchers from Fox Chase have shown that a newly developed compound was able to block necroptosis, a type of cell death following infection with the influenza virus. Read more from Siddharth Balachandran, PhD: bit.ly/3VWiFjQ

In a study published in the journal Nature, researchers from Fox Chase have shown that a newly developed compound was able to block necroptosis, a type of cell death following infection with the influenza virus. Read more from Siddharth Balachandran, PhD: bit.ly/3VWiFjQ
Fox Chase Cancer Center (@foxchasecancer) 's Twitter Profile Photo

Please join Fox Chase faculty for a free virtual educational workshop: Understanding Sarcoma and Leiomyosarcoma. The program will feature a panel of Fox Chase clinicians and researchers discussing promising treatments for sarcoma and leiomyosarcoma: bit.ly/3RZb2X8

Please join Fox Chase faculty for a free virtual educational workshop: Understanding Sarcoma and Leiomyosarcoma. The program will feature a panel of Fox Chase clinicians and researchers discussing promising treatments for sarcoma and leiomyosarcoma: bit.ly/3RZb2X8
Fox Chase Cancer Center (@foxchasecancer) 's Twitter Profile Photo

We're proud to share that Fox Chase Cancer Center has earned national rankings of 33 in cancer and 19 in urology among the country’s top 50 hospitals in the 2024-2025 Best Hospitals rankings from U.S. News & World Report: bit.ly/3WqeQDB

We're proud to share that Fox Chase Cancer Center has earned national rankings of 33 in cancer and 19 in urology among the country’s top 50 hospitals in the 2024-2025 Best Hospitals rankings from <a href="/usnews/">U.S. News & World Report</a>: bit.ly/3WqeQDB
Rebecca M. Shulman, MD (@rebeccamshulman) 's Twitter Profile Photo

Honored to serve as a moderator for the breast clinical trials session with Dr. Steve Chmura! Several exciting studies presented with a very thoughtful discussant, Asal Rahimi M.D., M.S. ! #ASTRO24

Fox Chase Cancer Center (@foxchasecancer) 's Twitter Profile Photo

Robert Freeman, MD, a second-year resident at Fox Chase and lead author of a study on adaptive radiation therapy, presented the ART study results yesterday at the American Society for Radiation Oncology (ASTRO) Annual Meeting in Washington, D.C.: bit.ly/4gLhj3w

Robert Freeman, MD, a second-year resident at Fox Chase and lead author of a study on adaptive radiation therapy, presented the ART study results yesterday at the American Society for Radiation Oncology (<a href="/ASTRO_org/">ASTRO</a>) Annual Meeting in Washington, D.C.: bit.ly/4gLhj3w
Fox Chase Cancer Center (@foxchasecancer) 's Twitter Profile Photo

Hilario Yankey, MD, MBA, recently joined Fox Chase as an Asst Professor in the Dept of Radiation Oncology. Yankey begins serving in this role following his completion of the Radiation Oncology Residency and Fellowship Training Program at Fox Chase in June: bit.ly/4eguisk

Hilario Yankey, MD, MBA, recently joined Fox Chase as an Asst Professor in the Dept of Radiation Oncology. Yankey begins serving in this role following his completion of the Radiation Oncology Residency and Fellowship Training Program at Fox Chase in June: bit.ly/4eguisk
ACRO - American College of Radiation Oncology (@acroradonc) 's Twitter Profile Photo

#CURiEAlert: "CT-Guided Adaptive Radiotherapy for the Treatment of Technically Challenging Oligometastatic Disease" by Drs. Peter Lee, Thomas Galloway, Xiaoming Chen, Ahmed ElDib, Mark Hallman, Charlie Ma, Josh Meyer & Rebecca M. Shulman, MD is now on CURiE: cureus.com/articles/28147…

#CURiEAlert: "CT-Guided Adaptive Radiotherapy for the Treatment of Technically Challenging Oligometastatic Disease" by Drs. Peter Lee, Thomas Galloway, Xiaoming Chen, Ahmed ElDib, Mark Hallman, Charlie Ma, <a href="/joshmeyer1/">Josh Meyer</a> &amp; <a href="/rebeccamshulman/">Rebecca M. Shulman, MD</a> is now on CURiE: cureus.com/articles/28147…
Fox Chase Cancer Center (@foxchasecancer) 's Twitter Profile Photo

Just a few days until Together Facing Breast Cancer, a free educational workshop at Fox Chase Cancer Center on 10/8/24. The program will feature a panel of Fox Chase clinicians and researchers discussing promising treatments for breast cancer: bit.ly/3Y8u018

Just a few days until Together Facing Breast Cancer, a free educational workshop at Fox Chase Cancer Center on 10/8/24. The program will feature a panel of Fox Chase clinicians and researchers discussing promising treatments for breast cancer: bit.ly/3Y8u018
Fox Chase Cancer Center (@foxchasecancer) 's Twitter Profile Photo

Thank you to everyone who attended our 23rd Annual Highlights of the 2024 San Antonio Breast Cancer Symposium, and congratulations to our Fox Chase 2024-2025 Breast Fellow, Walker Lyons, MD, this year’s winner of the Award for Best Poster.

Thank you to everyone who attended our 23rd Annual Highlights of the 2024 San Antonio Breast Cancer Symposium, and congratulations to our Fox Chase 2024-2025 Breast Fellow, Walker Lyons, MD, this year’s winner of the Award for Best Poster.
Miami Cancer Institute Research (@miamicancerinst) 's Twitter Profile Photo

The next sessions lead with different approaches for early stage #breastcancer 👇💡 Rebecca M. Shulman, MD focused on adjuvant radiation therapy and utilizing #APBI when needed. Dr. Pooja Advani on advancements with broadcast therapies, CDK 4/6 inhibitors & #immunotherapy.

The next sessions lead with different approaches for early stage #breastcancer 👇💡

<a href="/rebeccamshulman/">Rebecca M. Shulman, MD</a> focused on adjuvant radiation therapy and utilizing #APBI when needed.  

Dr. Pooja Advani on advancements with broadcast therapies, CDK 4/6 inhibitors &amp; #immunotherapy.
Miami Cancer Institute Research (@miamicancerinst) 's Twitter Profile Photo

đź’ˇLots of meaningful conversations on the trajectory of caring for patients with breast cancer during the afternoon Q&A session. What has been your favorite speaker or topic so far?

đź’ˇLots of meaningful conversations on the trajectory of caring for patients with breast cancer during the afternoon Q&amp;A session. 

What has been your favorite speaker or topic so far?
Lorenzo Galluzzi (@deadoc80) 's Twitter Profile Photo

Happy to share our recent Cell Research commentary on a recent Cancer Cell paper selective #CDK4 inhibition in #breastcancer. Kudos to to Manu taking the lead on this and thanks to Rebecca M. Shulman, MD for input!! Available at rdcu.be/ehCOo Fox Chase Cancer Center

Happy to share our recent <a href="/cell_res/">Cell Research</a> commentary on a recent <a href="/Cancer_Cell/">Cancer Cell</a> paper selective #CDK4 inhibition in #breastcancer. Kudos to to <a href="/Mbv26/">Manu</a>  taking the lead on this and thanks to <a href="/rebeccamshulman/">Rebecca M. Shulman, MD</a> for input!! Available at rdcu.be/ehCOo <a href="/FoxChaseCancer/">Fox Chase Cancer Center</a>
Rebecca M. Shulman, MD (@rebeccamshulman) 's Twitter Profile Photo

Supporting our breast cancer patients with the fam and extended Fox Chase Cancer Center fam this beautiful Sunday morning at the Susan G Komen More Than Pink Walk! Fox Chase Cancer Center Susan G. Komen

Supporting our breast cancer patients with the fam and extended Fox Chase Cancer Center fam this beautiful Sunday morning at the Susan G Komen More Than Pink Walk! <a href="/FoxChaseCancer/">Fox Chase Cancer Center</a> <a href="/SusanGKomen/">Susan G. Komen</a>